Jung-Ha Lee

Title: Jung-Ha Lee: Innovator in Calcium Channel Research

Introduction

Jung-Ha Lee is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biomedical research, particularly in the development of innovative cell lines for high throughput screening.

Latest Patents

Jung-Ha Lee holds a patent for a transfected cell line and a method using the same for the high throughput screening for inhibitors of the T-type calcium channel alpha-1H. This invention relates to a cell line in which a potassium channel is introduced. Specifically, it is a cell line capable of activating the T-type α1H calcium channel by depolarization, wherein a vector encoding a potassium channel is introduced. The cell line developed by Jung-Ha Lee is available for high throughput screening of candidate T-type α1H calcium channel inhibitors, which may accelerate the development of therapeutic agents for diseases related to T-type α1H calcium channels. He has 1 patent to his name.

Career Highlights

Jung-Ha Lee is affiliated with the Korea Institute of Science and Technology, where he conducts his research and development activities. His work has been instrumental in advancing the understanding of calcium channels and their implications in various diseases.

Collaborations

He has collaborated with notable colleagues, including Byong-Gon Park and Seong-Woo Jeong, to further enhance the impact of his research.

Conclusion

Jung-Ha Lee is a key figure in the field of calcium channel research, with a focus on developing innovative solutions for therapeutic applications. His contributions are paving the way for advancements in medical treatments related to calcium channels.